Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world study

Autor: Varnier, R., Toullec, C., Philonenko, S., Dupré, A., Artru, P., Hafliger, E., Drouillard, A., Torregrosa, C., Pernot, S., McLellan, P., Lecomte, T., Moulin, V., Lécaille, C., Touchefeu, Y., Locher, C., Taieb, J., Coutzac, C.
Zdroj: In Digestive and Liver Disease September 2024 56(9):1605-1613
Databáze: ScienceDirect